A randomized double‐blind placebo controlled phase I–II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or “chemopromotion”?

By  

THE PROSTATE, Vol. 75, Iss. 11, 2015-08 ,pp. : 1177-1186

John Wiley & Sons Inc

Access to resources Recommend Favorite

Apremilast in Patients With Active Rheumatoid Arthritis: A Phase II, Multicenter, Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐Group Study

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 7, 2015-07 ,pp. : 1703-1710

John Wiley & Sons Inc

Access to resources Recommend Favorite

A randomized, double‐blind, placebo‐controlled, phase II clinical trial to investigate the efficacy and safety of oral DA‐1229 in patients with type 2 diabetes mellitus who have inadequate glycaemic control with diet and exercise

By  

DIABETES/METABOLISM: RESEARCH AND REVIEWS (ELECT), Vol. 31, Iss. 3, 2015-03 ,pp. : 295-306

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epigallocatechin gallate enhances treatment efficacy of oral nifedipine against pregnancy‐induced severe pre‐eclampsia: A double‐blind, randomized and placebo‐controlled clinical study

By  

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 43, Iss. 1, 2018-02 ,pp. : 21-25

John Wiley & Sons Inc

Access to resources Recommend Favorite

Systematic Review on the Efficacy of Fexofenadine in Seasonal Allergic Rhinitis: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Clinical Trials

By  

International Archives of Allergy and Immunology, Vol. 156, Iss. 1, 2011-03 ,pp. : 1-15

Karger

Access to resources Recommend Favorite